. Author manuscript; available in PMC: 2006 Oct 3.

Published in final edited form as: Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1115–1123. doi: 10.1007/s00259-005-1853-5

Table 5.

Comparison between experimental and theoretical blood levels (%ID/g) in pretargeting with 30 μg MN14-MORF and 0.30 μg labeled cMORF

		Blood level of labeled cMORF
Pretargeting interval	Blood level of MN14-MORF^a	Theoretical^b	Experimental
2 days	1.94	1.38	1.27±0.17
3 days	1.02	0.77	0.93±0.08
4 days	0.53	0.44	0.58±0.13

Calculated from the antibody blood clearance curve

The theoretical blood level of labeled cMORF (%ID/g)=the blood level of antibody-MORF (%ID/g)×dose of antibody-MORF ÷ MW_antibody×gmp×MW_cMORF ÷ dose of labeled cMORF+background blood level of free labeled cMORF=the blood level of antibody-MORF (%ID/g)×30 μg÷160,000×0.17×6331÷0.30 μg+0.08. The 0.08 is from reference [18]